Old Web
English
Sign In
Acemap
>
authorDetail
>
Raymond Brig
Raymond Brig
Internal medicine
Medicine
Talazoparib
Oncology
Phases of clinical research
2
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Neoadjuvant talazoparib (TALA) in patients (pts) with germline BRCA1/2 (gBRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Exploration of tumor BRCA mutational status and zygosity and overall mutational landscape in a phase 2 study.
2021
Journal of Clinical Oncology
Melinda L. Telli
Jennifer K. Litton
Joseph Thaddeus Beck
Jason M. Jones
Jay Andersen
Lida A. Mina
Raymond Brig
Michael A. Danso
Yuan Yuan
William Fraser Symmans
Antonello Abbattista
Kay Noonan
Marielena Mata
Douglas Laird
Joanne L. Blum
Show All
Source
Cite
Save
Citations (1)
Neoadjuvant talazoparib in patients with germline BRCA1/2 (gBRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Results of a phase 2 study
2021
Journal of Clinical Oncology
Jennifer K. Litton
Jt Beck
Jason M. Jones
Jay Andersen
Joanne L. Blum
Lida A. Mina
Raymond Brig
Michael A. Danso
Yuan Yuan
Antonello Abbattista
Kay Noonan
Jayeta Chakrabarti
Akos Czibere
William Fraser Symmans
Melinda L. Telli
Show All
Source
Cite
Save
Citations (5)
1